Principal Financial Group Inc Aclaris Therapeutics, Inc. Transaction History
Principal Financial Group Inc
- $162 Billion
- Q1 2024
A detailed history of Principal Financial Group Inc transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 17,654 shares of ACRS stock, worth $19,419. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,654
Previous 19,419
9.09%
Holding current value
$19,419
Previous $20,000
5.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ACRS
# of Institutions
102Shares Held
53.5MCall Options Held
51KPut Options Held
31.6K-
Bml Capital Management, LLC Zionsville, IN9.4MShares$10.3 Million7.8% of portfolio
-
Black Rock Inc. New York, NY5.2MShares$5.72 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.93MShares$5.42 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.28MShares$3.61 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.27MShares$3.6 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $73.3M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...